FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

Generative AI, intelligent agents, and frontier models are giving rise to a new category of software that I believe will redefine how work gets done. For decades, we have built systems of record and ...

Controlling light at the micro- and nanoscale opens up opportunities for a better understanding of the world and the development of technology. As modern electronics approaches the limits of its ...

In a quiet hall at the DRIMS School System, dozens of students bent over their desks, carefully shaping lines across blank pages.To an outside observer, the exercise might look simple. But for the 50 ...

This call for articles and short reports is to enhance our understanding of the function and evolution of short genomic ...

How Can Organizations Effectively Protect Non-Human Identities Online? Are your machine identities adequately protected against cyber threats? Where the integrity of digital identity is paramount, the ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Before AI can transform healthcare, someone has to fix the infrastructure underneath it. As Senior Analytics Engineer Mehulkumar Joshi embedded inside some of t ...

What is CPU mining? Know the history of Bitcoin mining, how central processing units validate blockchain transactions, and ...

The SkyClimb Method shifts the focus from external behaviors to the internal systems that influence a child’s ability ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...